Skip to main content

Navigation group

Type at least 3 characters
580 articles

Articles

Original Research

Published on 10 Nov 2020

Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi‐Organ Failure

in Respiratory Pharmacology

  • Fatih M. Uckun
  • James Carlson
  • Cemal Orhan
  • Joy Powell
  • Natalie M. Pizzimenti
  • Hendrik van Wyk
  • Ibrahim H. Ozercan
  • Michael Volk
  • Kazim Sahin
Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi‐Organ Failure
Frontiers in Pharmacology
doi 10.3389/fphar.2020.594321
  • 10,408 views
  • 20 citations